Insider profile
Drugs Made In America Acquisition II LLC Insider Trading
This page tracks every SEC Form 4 filing since April 2023 by Drugs Made In America Acquisition II LLC: 4 transactions in total, including 2 open-market purchases and 1 sale. Each record is parsed directly from the original filing, with amendments reconciled so a corrected filing never double-counts.
- CIK
- 0002088432
- Companies traded
- 1
- Total filings
- 4
- First filing
- 2025-09-26
- Last filing
- 2025-09-26
Files as Drugs Made In America Acquisition II LLC · SEC EDGAR ↗
Activity summary
The most recent open-market activity, on September 26, 2025, was mixed: 2 purchases totaling 1,400,000 shares and 1 sale totaling 7,966,667 shares.
Insider insight
Drugs Made In America Acquisition II LLC trades most actively in DMII, accounting for 2 of the 4 filings on record.
Track record
Most active in
Transaction History
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | DMII | Sale | 7,966,667 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | DMII | Purchase | 700,000 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | DMII | J | 400,000 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | DMII | Purchase | 700,000 | — | — |
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/insiders/0002088432/transactions" \
-H "X-Api-Key: $KEY"Companies traded
By number of filings.
Filing cadence
Filings per quarter, this window.
Busiest: Q3 25 (4 filings)
Reading an insider's Form 4 history
Corporate insiders (directors, officers, and holders of more than 10% of a company's stock) must report their trades to the SEC on Form 4 within two business days. Looking at one insider's filings over time shows whether they tend to buy on the open market (a discretionary use of their own money, generally the strongest signal), sell, or simply receive and exercise equity awards as compensation.
The track record above measures how this insider's past open-market purchases performed in the months after each filing. Trades made under a pre-scheduled Rule 10b5-1 plan are flagged because they carry no timing signal. To pull any insider's full history programmatically, see the insider trading API or our guide to reading Form 4 filings.